-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WJuyQMqyZk4ETKu/51kT6jv2uJHmvizX8HEg/+cEQhnjoQnjqeUpCwXQ7Ai6BNIc SmUJjV9opO6sj6N/1FUKGg== 0000736822-02-000011.txt : 20020413 0000736822-02-000011.hdr.sgml : 20020413 ACCESSION NUMBER: 0000736822-02-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20011231 FILED AS OF DATE: 20020110 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IMMUCOR INC CENTRAL INDEX KEY: 0000736822 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 222408354 STATE OF INCORPORATION: GA FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14820 FILM NUMBER: 2506715 BUSINESS ADDRESS: STREET 1: 3130 GATWAY STREET 2: PO BOX 5625 CITY: NORCROSS STATE: GA ZIP: 30091 BUSINESS PHONE: 7704412051 MAIL ADDRESS: STREET 1: 3130 GATEWAY DR STREET 2: P O BOX 5625 CITY: NORCROSS STATE: GA ZIP: 30091-5625 COMPANY DATA: COMPANY CONFORMED NAME: IMMUCOR INC CENTRAL INDEX KEY: 0000736822 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] DIRECTOR IRS NUMBER: 222408354 STATE OF INCORPORATION: GA FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 3130 GATWAY STREET 2: PO BOX 5625 CITY: NORCROSS STATE: GA ZIP: 30091 BUSINESS PHONE: 7704412051 MAIL ADDRESS: STREET 1: 3130 GATEWAY DR STREET 2: P O BOX 5625 CITY: NORCROSS STATE: GA ZIP: 30091-5625 4 1 form4jr.txt FORM4JOEROSEN0102 January 10, 2002 Securities and Exchange Commission Washington DC 20549 Dear Sir or Madam: On behalf of Joseph Rosen, who is a Director of Immucor, Inc. (the "Company"), we are transmitting the Statement of Changes in Beneficial Ownership on Form 4 with respect to the Company's Common Stock. Sincerely, /s/ Edward L. Gallup Edward L. Gallup President U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4 Statement of Changes in Beneficial Ownership Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 ___ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instructions 1(b). 1. Name and Address of Reporting Person Joseph E. Rosen 31 Grasmere Way Princeton, NJ 08540 2. Issuer Name and Ticker or Trading Symbol Immucor, Inc./BLUD 3. IRS or Social Security Number of Reporting Person (Voluntary) ###-##-#### 4. Statement for Month/Year 12/01 5. If Amendment, Date of Original (Month/Year) NA 6. Relationship of Reporting Person to Issuer (check all applicable) X Director Officer (give title below) 10% Owner Other (specify below) TABLE I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr.3) NA 2. Transaction Date (Month/Day/Year) NA 3. Transaction Code (Instr. 8) NA 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) Amount (A) or (D) Price NA 5. Amount of Securities 6. Ownership Form: 7. Nature of Indirect Beneficially Owned at Direct (D) or Beneficial Ownership End of Month Indirect (I) (Instr. 4) (Instr. 3 and 4) (Instr. 4) 1,000 D N/A 1,000 I by IRA ------ 2,000 (as previously reported) TABLEII - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) Stock Option - Right to buy 2. Conversion or Exercise Price of Derivative Security $6.75 3. Transaction Date (Month/Day/Year) 12/3/01 4. Transaction Code (Instr. 8) T 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) Options as previously reported 10,000 (A) (D) 10,000 NA 6. Date Exercisable and Expiration Date (Month/Day/Year) Date Exercisable Expiration Date 12/3/03 12/3/11 7. Title and Amount of Underlying Securities (Instr. 3 and 4) Title Amount or Number of Shares 12/3/03 10,000 8. Price of Derivative Security (Instr. 5) NA 9. Number of Derivative Securities Beneficially Owned at End of Year (Instr. 4) 13,000 (as previously reported) 10,000 derivative securities acquired -------- 23,000 Total owned at end of year 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) D 11. Nature of Indirect Beneficial Ownership (Instr. 4) NA Explanation of Responses: Stock options are exercisable 50% on 12/3/03, and 25% on 12/3/04 and 12/3/05. /s/Joseph E. Rosen, by Steven C. Ramsey as Power of Attorney - ------------------------------------------------------------ Signature of Reporting Person 1/10/02 Date -----END PRIVACY-ENHANCED MESSAGE-----